Evidence map›Paper›PMID 41851533›Full record

ArticleLangenbeck's archives of surgery2026

Topographic sketching for surgical planning after neoadjuvant chemotherapy in breast cancer: a non-invasive localization method.

Mahmut Muslumanoglu, Baran Mollavelioglu, Selman Emiroglu, Hasan Berke Atalay, Neslihan Cabioglu, Ravza Yılmaz, Rana Gunoz Comert, Aysel Bayram, Sidar Bagbudar, Melin Aydan Ahmed and 1 more

Abstract read
In one paragraph

Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mahmut MuslumanogluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey.
Baran MollaveliogluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey. baran.mollavelioglu@istanbul.edu.tr.ORCID http://orcid.org/0000-0003-3152-044X
Selman EmirogluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey.
Hasan Berke AtalayDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey.
Neslihan CabiogluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey.
Ravza YılmazDepartment of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Rana Gunoz ComertDepartment of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Aysel BayramDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sidar BagbudarDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Melin Aydan AhmedDepartment of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey.
Mustafa TükenmezDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Avenue, 34093, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNeoadjuvant chemotherapy (NAC) is widely adopted as the standard treatment for locally advanced breast cancer. However, following NAC, tumors may become non-palpable due to complete or partial response, making it challenging to achieve adequate margins in breast-conserving surgery (BCS). Various tumor localization techniques have been developed to address this issue. This study compares traditional clip and wire-guided marking (Radiological Marking, RM) with a non-invasive technique called Topographic Sketching (TS).

methodsThis retrospective study included 208 patients who underwent BCS after their tumors became non-palpable post-NAC. A total of 102 patients underwent RM using radiopaque clips followed by wire-guided excision, while 106 patients were treated using the TS technique. In the TS group, pre-NAC imaging and physical examination were used to determine the tumor’s location, distance from anatomical landmarks, and skin projection. These data were documented photographically and archived. Post-NAC, the tumor site was re-evaluated, and the excision was guided by redrawn topographic markings based on both archival and current imaging data.

resultsAmong the participants, 91 patients showed complete response and 117 showed partial response to NAC. Unifocal tumors were observed in 168 patients, and multifocal tumors in 40. Only one patient from each group required a second surgery due to positive surgical margins. During a median follow-up of five years, six patients experienced local recurrence. There were no statistically significant differences between the RM and TS groups in terms of patient age, tumor stage, nodal status, multifocality, pathological response, or molecular subtype.

conclusionTopographic sketching is a promising, non-invasive, and cost-effective alternative to clip and wire-guided localization. It provides critical information about the tumor’s original borders and is comparably effective in terms of surgical outcomes and recurrence rates.

Indexed as

Breast NeoplasmsMastectomy, SegmentalNeoadjuvant TherapyAdultAgedChemotherapy, AdjuvantFemaleHumansMargins of ExcisionMiddle AgedRetrospective StudiesTreatment OutcomeBreast-conserving surgeryGuide wireLocalization methodMetallic markerNeoafjuvant chemotherapyTumor marking

Identifiers

PMID41851533
PMCPMC13121214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.